Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Company Profile Financials Financial Details

Financial Details

Highlights

Frazier Life Sciences has made 57 investments. Their most recent investment was on
obfuscation
, when Maze Therapeutics raised
obfuscation
.Frazier Life Sciences has raised a total of
obfuscation
across 5 funds, their latest being Frazier Life Sciences XII. This fund was announced on
obfuscation
and raised a total of
obfuscation
.Frazier Life Sciences has made 4 diversity investments. Their most recent diversity investment was on
obfuscation
, when Parabilis Medicines raised
obfuscation
.Frazier Life Sciences has had
obfuscation
exit, which was Parabilis Medicines. Frazier Life Sciences has had
obfuscation
exits. Frazier Life Sciences's most notable exits include Parabilis Medicines, Jade Biosciences, and  Tubulis.
Lead Investments 15
Investments 57
Exits 
obfuscation
Funds 5

Investments

Number of Portfolio Organizations 41
Number of Investments 57
Frazier Life Sciences has made 57 investments. Their most recent investment was on
obfuscation
, when Maze Therapeutics raised
obfuscation
.
How many investments has this organization made over time?
Which industries has this organization most actively invested in?
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Maze Therapeutics Logo
Maze Therapeutics
—
Post-IPO Equity - Maze Therapeutics Logo
Post-IPO Equity - Maze Therapeutics
obfuscation
obfuscation
Maze Therapeutics Logo
Maze Therapeutics
—
Post-IPO Equity - Maze Therapeutics Logo
Post-IPO Equity - Maze Therapeutics
obfuscation
obfuscation
Maze Therapeutics Logo
Maze Therapeutics
—
Post-IPO Equity - Maze Therapeutics Logo
Post-IPO Equity - Maze Therapeutics
obfuscation
obfuscation
Maze Therapeutics Logo
Maze Therapeutics
—
Post-IPO Equity - Maze Therapeutics Logo
Post-IPO Equity - Maze Therapeutics
obfuscation
obfuscation
Maze Therapeutics Logo
Maze Therapeutics
—
Post-IPO Equity - Maze Therapeutics Logo
Post-IPO Equity - Maze Therapeutics
obfuscation

Funds Raised

Number of Funds 5
Total Fund Raised 
obfuscation
Frazier Life Sciences has raised a total of
obfuscation
across 5 funds, their latest being Frazier Life Sciences XII. This fund was announced on
obfuscation
and raised a total of
obfuscation
.
Announced Date  
Fund Name  
Money Raised  
obfuscation
Frazier Life Sciences XII Logo
Frazier Life Sciences XII
obfuscation
obfuscation
Frazier Life Sciences Public Overage Fund Logo
Frazier Life Sciences Public Overage Fund
obfuscation
obfuscation
Frazier Life Sciences XI Logo
Frazier Life Sciences XI
obfuscation
obfuscation
Frazier Life Sciences Public Fund Logo
Frazier Life Sciences Public Fund
obfuscation
obfuscation
Frazier Life Sciences VIII Logo
Frazier Life Sciences VIII
obfuscation

Diversity Investments

Number of Diversity Investments 4
Frazier Life Sciences has made 4 diversity investments. Their most recent diversity investment was on
obfuscation
, when Parabilis Medicines raised
obfuscation
.
Announced Date  
Organization Name  
Diversity Spotlight  
Funding Round  
Money Raised  
obfuscation
Parabilis Medicines Logo
Parabilis Medicines
Women Founded
Series F - Parabilis Medicines Logo
Series F - Parabilis Medicines
obfuscation
obfuscation
Trevi Therapeutics Logo
Trevi Therapeutics
Women Founded, Women Led
Post-IPO Equity - Trevi Therapeutics Logo
Post-IPO Equity - Trevi Therapeutics
obfuscation
obfuscation
Applied Therapeutics Logo
Applied Therapeutics
Women Founded, Women Led
Post-IPO Equity - Applied Therapeutics Logo
Post-IPO Equity - Applied Therapeutics
obfuscation
obfuscation
Trevi Therapeutics Logo
Trevi Therapeutics
Women Founded, Women Led
Post-IPO Equity - Trevi Therapeutics Logo
Post-IPO Equity - Trevi Therapeutics
obfuscation

Exits

Number of Exits 
obfuscation
Frazier Life Sciences has had
obfuscation
exit, which was Parabilis Medicines. Frazier Life Sciences has had
obfuscation
exits. Frazier Life Sciences's most notable exits include Parabilis Medicines, Jade Biosciences, and  Tubulis.
Which industries has this organization had the most exits in?
Parabilis Medicines Logo
Parabilis MedicinesParabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Jade Biosciences Logo
Jade BiosciencesJade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Tubulis Logo
TubulisTubulis is a biotechnology company that develops antibody-drug conjugates (ADCs) for targeted cancer therapy.
Disc Medicine Logo
Disc MedicineDisc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Palvella Therapeutics Logo
Palvella TherapeuticsPalvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
LEXEO Therapeutics Logo
LEXEO TherapeuticsLEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
MBX Biosciences Logo
MBX BiosciencesMBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Maze Therapeutics Logo
Maze TherapeuticsMaze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
AN2 Therapeutics Logo
AN2 TherapeuticsAN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.
Xilio Therapeutics Logo
Xilio TherapeuticsXilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d29fb2e 1)
|